Prognostic effects of abnormal DNA damage response protein expression in breast cancer-Reference-Cited by-同舟云学术

Prognostic effects of abnormal DNA damage response protein expression in breast cancer

Published:2019-01-22 Issue:1 Volume:175 Page:117-127
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Suh Koung Jin,Ryu Han Suk,Lee Kyung-Hun,Kim Hyojin,Min Ahrum,Kim Tae-Yong,Yang Yaewon,Lee Han-Byoel,Moon Hyeong-Gon,Han Sae-Won,Oh Do-Youn,Han Wonshik,Park In Ae,Noh Dong-Young,Im Seock-Ah

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05128-9.pdf

Reference25 articles.

1. Stracker TH, Roig I, Knobel PA, Marjanović M (2013) The ATM signaling network in development and disease. Front Genet 4:37. https://doi.org/10.3389/fgene.2013.00037

2. Paull TT (2015) Mechanisms of ATM activation. Annu Rev Biochem 84:711–738. https://doi.org/10.1146/annurev-biochem-060614-034335

3. Lee J-M, Ledermann JA, Kohn EC (2014) PARP inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies. Ann Oncol 25:32–40. https://doi.org/10.1093/annonc/mdt384

4. Farmer H, McCabe N, Lord CJ et al (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917–921. https://doi.org/10.1038/nature03445

5. Liu X, Holstege H, van der Gulden H et al (2007) Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci USA 104:12111–12116. https://doi.org/10.1073/pnas.0702969104

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication of a wood-based molecularly imprinted composite with pH/temperature-response for specific recognition of OVA;Separation and Purification Technology;2024-08

2. Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes;Cancer Immunology, Immunotherapy;2024-02-13

3. Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress;Frontiers in Oncology;2023-10-03

4. Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population;Frontiers in Oncology;2023-04-27

5. Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?;Journal of Clinical Medicine;2023-04-20